selected scholarly activity
-
conferences
- Long-term effectiveness and safety of infliximab and golimumab in ankylosing spondylitis patients from a Canadian prospective observational registry. BMC Rheumatology. 56. 2020
- Incidence of infusion reactions to intravenous golimumab: results from a prospective, real-world community registry. Clinical and Experimental Rheumatology. 371-371. 2020
- AB0704 EFFECTIVENESS AND SAFETY OF INFLIXIMAB AND GOLIMUMAB IN ANKYLOSING SPONDYLITIS PATIENTS FROM A PROSPECTIVE OBSERVATIONAL REGISTRY. Annals of the Rheumatic Diseases. 1814-1814. 2019
- EFFECTIVENESS AND SAFETY OF INFLIXIMAB AND GOLIMUMAB IN ANKYLOSING SPONDYLITIS FROM A LONGITUDINAL OBSERVATIONAL REGISTRY. Journal of Clinical Rheumatology. S63-S63. 2019
- Improvement in Work Productivity and Fatigue of Certolizumab Pegol in Rheumatoid Arthritis Patients in a Canadian Practice Setting: Two Year Results from the Non-Interventional F-alphasT CAN Study. Journal of Rheumatology. 1050-1050. 2018
- Incidence of Extra-Articular Manifestations in PsA and AS Patients Treated with Golimumab in Canadian Real-World. Journal of Rheumatology. 1020-1020. 2018
- Incidence of Infusion Reactions to Intravenous Golimumab: Results from a Prospective, Real-World Community Registry. Journal of Rheumatology. 1034-1034. 2018
- Predictors of Long-Term Retention of Methotrexate and Other DMARDs with Golimumab in Rheumatoid Arthritis and Psoriatic Arthritis: An Analysis from a Prospective, Observational Registry. Journal of Rheumatology. 978-978. 2018
- Safety and Effectiveness of Ustekinumab for the Treatment of Psoriatic Arthritis over a 6 Month Period. Journal of Rheumatology. 1033-1033. 2018
- The Effectiveness and Safety of Certolizumab Pegol in Rheumatoid Arthritis Patients in a Canadian Practice Setting: Two Year Results from the Non-Interventional F-alphasT CAN Study. Journal of Rheumatology. 1050-1050. 2018
- GRADE-Based Recommendations for the Diagnosis and Monitoring of Systemic Lupus Erythematosus in Canada. Arthritis & Rheumatology. 2017
- Incidence of Extra-Articular Manifestations in Psa and As Patients Treated with Golimumab in Canadian Real-World. Arthritis & Rheumatology. 2017
- Predictors of Long-Term Retention of Methotrexate and Other Dmards with Golimumab in Rheumatoid Arthritis and Psoriatic Arthritis: An Analysis from a Prospective, Observational Registry. Arthritis & Rheumatology. 2017
- Safety and Effectiveness of Ustekinumab for the Treatment of Psoriatic Arthritis over a 6 Month Period. Arthritis & Rheumatology. 2017
- Automated Data Extraction from Electronic Medical Records in Rheumatology: An Ontario Best Practices Research Initiative Pilot Project (OBRI). Journal of Rheumatology. 863-864. 2017
- Comparison of Baseline Characteristics of Psoriatic Arthritis Patients Initiating Therapy with Subcutaneous Golimumab or Ustekinumab: An Analysis from a Prospective, Observational Registry. Journal of Rheumatology. 918-919. 2017
- Impact of HLA-B27 on Patient Profile and Treatment Response in AS Patients Treated with Anti-TNF in Canadian Real-world Setting. Journal of Rheumatology. 910-910. 2017
- Predictors of Golimumab Retention among Patients with Rheumatoid Arthritis on Stable Treatment in Canadian Real-world Setting. Journal of Rheumatology. 921-921. 2017
- Impact of HLA-B27 on Patient Profile and Treatment Response in As Patients Treated with Anti-TNF in Canadian Real-World. Arthritis & Rheumatology. 2016
- T Cell Epitopes Stimulating TGF beta in Patients with Systemic Sclerosis: Towards a Vaccine. Journal of Rheumatology. 1315-1316. 2015
- A CASE OF HASHIMOTO'S ENCEPHALOPATHY TREATED WITH IMMUNOMODULATION AND THYROIDECTOMY WITH INCIDENTAL FINDING OF THYROID CANCER.. Annals of Allergy, Asthma and Immunology. A67-A67. 2014
- Oncogenic osteomalacia. A case report and literature review. Journal of Rheumatology. 1200-1201. 2008
- Predictors of osteoporosis diagnosis among patients with fragility hip fracture. Journal of Rheumatology. 400-400. 2006
- Knowledge dissemination strategies translate into improved post-fracture osteoporosis care. Journal of Bone and Mineral Research. S264-S264. 2005
-
journal articles
- Risk factors for prevalent and incident hypertension in rheumatoid arthritis: data from the Canadian Early Arthritis Cohort. Rheumatology Advances in Practice. 8:rkae066. 2024
- Real-World Effectiveness of Upadacitinib for Treatment of Rheumatoid Arthritis in Canadian Patients: Interim Results from the Prospective Observational CLOSE-UP Study. Rheumatology and Therapy. 11:563-582. 2024
- Factors affecting the discrepancy between patient and physician global assessment in early rheumatoid arthritis: The Ontario Best Practices Research Initiative.. Clinical and Experimental Rheumatology. 41:2249-2256. 2023
- Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post‐hoc analysis of clinical trials. International Journal of Rheumatic Diseases. 26:1248-1259. 2023
- Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data. Rheumatology and Therapy. 10:693-706. 2023
- “From Where I Stand”: using multiple anchors yields different benchmarks for meaningful improvement and worsening in the rheumatoid arthritis flare questionnaire (RA-FQ). Quality of Life Research. 32:1307-1318. 2023
- Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational Study. Arthritis Care and Research. 75:240-251. 2023
- Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 Study. Rheumatology and Therapy. 10:275-292. 2023
- Physician- and Patient-reported Effectiveness Are Similar for Tofacitinib and TNFi in Rheumatoid Arthritis: Data From a Rheumatoid Arthritis Registry. Journal of Rheumatology. 49:447-453. 2022
- A Bridge Too Far? Real‐World Practice Patterns of Early Glucocorticoid Use in the Canadian Early Arthritis Cohort. ACR Open Rheumatology. 4:57-64. 2022
- Disease activity trajectories for early and established rheumatoid arthritis: Real-world data from a rheumatoid arthritis cohort. PLoS ONE. 17:e0274264-e0274264. 2022
- Heterogeneity in Patient Characteristics and Differences in Treatment Across 4 Canadian Rheumatoid Arthritis Cohorts. Journal of Rheumatology. 49:16-25. 2022
- Upadacitinib in patients with psoriatic arthritis and an inadequate response to non-biological therapy: 56-week data from the phase 3 SELECT-PsA 1 study. RMD Open. 7:e001838-e001838. 2021
- Health Assessment Questionnaire at One Year Predicts All‐Cause Mortality in Patients With Early Rheumatoid Arthritis. Arthritis & Rheumatology. 73:197-202. 2021
- Corrigendum to: Incidence and prevalence of giant cell arteritis in Ontario, Canada. Rheumatology. 59:3584-3584. 2020
- Incidence and prevalence of giant cell arteritis in Ontario, Canada. Rheumatology. 59:3250-3258. 2020
- Treatment Strategies in Early Rheumatoid Arthritis Methotrexate Management: Results From a Prospective Cohort. Arthritis Care and Research. 72:1104-1111. 2020
- Palindromic Rheumatism Frequently Precedes Early Rheumatoid Arthritis: Results From an Incident Cohort. ACR Open Rheumatology. 1:614-619. 2019
- Collection of antirheumatic medication data from both patients and rheumatologists shows strong agreement in a real-world clinical cohort: the Ontario Best Practices Research Initiative—a rheumatoid arthritis cohort. Journal of Clinical Epidemiology. 114:95-103. 2019
- Joint Estimation of Remission and Response for Methotrexate‐Based DMARD Options in Rheumatoid Arthritis: A Bivariate Network Meta‐Analysis. ACR Open Rheumatology. 1:471-479. 2019
- Effect of Concomitant Disease-modifying Antirheumatic Drugs and Methotrexate Administration Route on Biologic Treatment Durability in Rheumatoid Arthritis: OBRI Cohort Results. Journal of Rheumatology. 46:874-886. 2019
- Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study. Therapeutic Advances in Musculoskeletal Disease. 11:1759720X1983115-1759720X1983115. 2019
- Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus. Journal of Rheumatology. 45:1426-1439. 2018
- Overweight, Obesity, and the Likelihood of Achieving Sustained Remission in Early Rheumatoid Arthritis: Results From a Multicenter Prospective Cohort Study. Arthritis Care and Research. 70:1185-1191. 2018
- Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study. The Lancet. 391:2213-2224. 2018
- High Adherence to System‐Level Performance Measures for Rheumatoid Arthritis in a National Early Arthritis Cohort Over Eight Years. Arthritis Care and Research. 70:842-850. 2018
- The effect of rheumatoid arthritis–associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis. Rheumatology. 56:kew474-kew474. 2017
- Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double‐Blind, Placebo‐Controlled Trials. Arthritis & Rheumatology. 69:362-375. 2017
- Successful treatment of recurrent pleural and pericardial effusions with tocilizumab in a patient with systemic lupus erythematous. BMJ Case Reports. 2016:bcr2016215423-bcr2016215423. 2016
- Anti-cyclic citrullinated peptide antibody as a marker of erosive arthritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Lupus. 23:1156-1163. 2014
- Development and Validation of a Pediatric IBD Knowledge Inventory Device. Journal of Pediatric Gastroenterology and Nutrition. 58:313-319. 2014
- Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial. The Lancet. 382:780-789. 2013
- Closing the osteoporosis care gap – Increased osteoporosis awareness among geriatrics and rehabilitation teams. BMC Geriatrics. 9:28. 2009
- Is Regular Exercise a Friend or Foe of the Aging Immune System? A Systematic Review. Clinical Journal of Sport Medicine. 18:539-548. 2008
- The Relationship Between Exercise and Osteoarthritis in the Elderly. Clinical Journal of Sport Medicine. 18:508-521. 2008